Unknown

Dataset Information

0

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.


ABSTRACT:

Background

Testicular germ cell tumors (TGCTs) belong to the most chemosensitive solid tumors; however, a small proportion of patients fail to be cured with cisplatin-based chemotherapy. Inhibitors of PD-1/PD-L1 pathways represent a new class of promising drugs in anticancer therapy. The aim of this study was to evaluate expression and prognostic value of PD-1 and PD-L1 in TGCTs.

Patients and methods

Surgical specimens from 140 patients with TGCTs (131 with primary testicular tumor and 9 with extragonadal GCTs) were included into the translational study. PD-1 and PD-L1 expression was detected in the tumor tissue by immunohistochemistry using monoclonal antibodies, scored by the multiplicative quickscore (QS) method, compared with their expression in normal testicular tissue and correlated with clinicopathological characteristics and clinical outcome.

Results

None of the GCTs exhibited PD-1 protein, although expression of PD-L1 was significantly higher in GCTs in comparison with normal testicular tissue (mean QS = 5.29 versus 0.32, P < 0.0001). Choriocarcinomas exhibit the highest level of PD-L1 with decreasing positivity in embryonal carcinoma, teratoma, yolk sac tumor and seminoma. PD-L1 expression was associated with poor prognostic features, including ?3 metastatic sites, increased serum tumor markers and/or non-pulmonary visceral metastases. Patients with low PD-L1 expression had significantly better progression-free survival [hazard ratio (HR) = 0.40, 95% confidence interval (CI) 0.16-1.01, P = 0.008] and overall survival (HR = 0.43, 95% CI 0.15-1.23, P = 0.040) compared with patients with high PD-L1 expression.

Conclusions

In this translational study, we showed, for the first time, the prognostic value of PD-L1 expression in TGCTs and our data imply that the PD-1/PD-L1 pathway could be a novel therapeutic target in TGCTs.

SUBMITTER: Cierna Z 

PROVIDER: S-EPMC4751222 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.

Cierna Z Z   Mego M M   Miskovska V V   Machalekova K K   Chovanec M M   Svetlovska D D   Hainova K K   Rejlekova K K   Macak D D   Spanik S S   Ondrus D D   Kajo K K   Mardiak J J   Babal P P  

Annals of oncology : official journal of the European Society for Medical Oncology 20151123 2


<h4>Background</h4>Testicular germ cell tumors (TGCTs) belong to the most chemosensitive solid tumors; however, a small proportion of patients fail to be cured with cisplatin-based chemotherapy. Inhibitors of PD-1/PD-L1 pathways represent a new class of promising drugs in anticancer therapy. The aim of this study was to evaluate expression and prognostic value of PD-1 and PD-L1 in TGCTs.<h4>Patients and methods</h4>Surgical specimens from 140 patients with TGCTs (131 with primary testicular tumo  ...[more]

Similar Datasets

| S-EPMC5400624 | biostudies-literature
| S-EPMC5641527 | biostudies-literature
| S-EPMC6036896 | biostudies-other
| S-EPMC5363530 | biostudies-literature
| S-EPMC6803548 | biostudies-literature
| S-EPMC6141709 | biostudies-literature
| S-EPMC8809998 | biostudies-literature
| S-EPMC6474755 | biostudies-literature
| S-EPMC5601941 | biostudies-literature
| S-EPMC7416570 | biostudies-literature